journal article·2015-01

Characterisation and Comparison of the Host Response of 6 Tissue-Based Surgical Implants in a Subcutaneous in vivo Rat Model

Nicholas Bryan, Helen Ashwin, Neil J. Smart, Stephen Wohlert, Yves Bayon, John A. Hunt

Publisher page

Abstract

Background Hernia repair often involves fascial augmentation using biologic prostheses. Small processing changes during preparation modulate host tissue response, which influence material efficacy and longevity. In this pilot study, a rat model was used to determine the specific influence of tissue origin, decellularisation treatment and 1,6-hexamethylene diisocyanate (HMDI) cross-linking. Methods Materials (1 cm 2 ) were implanted subcutaneously into 6-week-old Wistar rats (4 materials per animal, n=6/material per time point) for 2, 5, 7, 14 and 28 days. Histologic processing was carried out after resin infiltration, observing classical histopathology and pathologic indexing. Materials comprised 6 tissue-based grafts covering both experimental and commercial porcine decellularised dermal and small intestinal submucosal materials. Results Subcutaneous delivery of biologics demonstrated material-specific inflammatory/host responses. Controlled variations of the Permacol™ manufacturing process showed sodium dodecyl sulfate (SDS) was the most proinflammatory decellularisation reagent, and HMDI cross-linking had no effect on host response. All materials remained recoverable after 28 days, although Surgisis™ had partially resorbed. Conclusion Differences in host responses exist between biologic implants for hernia repair in this rat model. It is postulated that these modifications are induced during processing and may have an effect on the clinical outcome of hernia repair.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hernia repair and management · Tissue Engineering and Regenerative Medicine · Intestinal and Peritoneal Adhesions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Clinical Engineering (UKCTE), The Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool - UK

Covidien — Sofradim Production, Trevoux - France

Exeter Health Sciences Research Unit, Royal Devon & Exeter Hospital, Exeter, Devon - UK

References (45)

Show source-provided references
1. 10.1007/s10029-007-0240-510.1007/s10029-007-0240-5 ↗
2. 10.1177/155335060933139710.1177/1553350609331397 ↗
3. 10.1016/j.surge.2012.02.00610.1016/j.surge.2012.02.006 ↗
4. Smart NJ · Surg Innov · 2011 · 221
5. 10.1586/17434440.3.5.65710.1586/17434440.3.5.657 ↗
6. 10.1016/S0039-6109(02)00196-210.1016/S0039-6109(02)00196-2 ↗
7. 10.1016/j.tcb.2005.09.00210.1016/j.tcb.2005.09.002 ↗
8. 10.1016/j.ijsu.2008.02.00510.1016/j.ijsu.2008.02.005 ↗
9. 10.1016/j.tibtech.2005.10.00610.1016/j.tibtech.2005.10.006 ↗
10. 10.1016/j.biocel.2003.12.00310.1016/j.biocel.2003.12.003 ↗
11. 10.1016/j.phrs.2008.07.00910.1016/j.phrs.2008.07.009 ↗
12. 10.1016/j.cyto.2005.06.01510.1016/j.cyto.2005.06.015 ↗
13. 10.1172/JCI11684110.1172/JCI116841 ↗
14. 10.1016/0007-1226(90)90185-310.1016/0007-1226(90)90185-3 ↗
15. 10.1016/j.imbio.2009.03.00910.1016/j.imbio.2009.03.009 ↗
16. 10.1016/j.suc.2010.08.00310.1016/j.suc.2010.08.003 ↗
17. 10.1016/j.injury.2006.02.03510.1016/j.injury.2006.02.035 ↗
18. 10.1016/S0002-9610(03)00296-410.1016/S0002-9610(03)00296-4 ↗
19. 10.1038/labinvest.378006710.1038/labinvest.3780067 ↗
20. 10.1016/j.intimp.2010.08.01210.1016/j.intimp.2010.08.012 ↗
21. 10.1016/j.biocel.2007.11.00810.1016/j.biocel.2007.11.008 ↗
22. KiklyK LotzeMT The skin and normal wound healing process In: LotzeMT ThomsonAW eds. Dendritic cells. 2nd ed. Elsevier; Netherlands 2001 539–545.10.1016/B978-012455851-9/50077-8 ↗
23. 10.1016/S0015-0282(00)00490-810.1016/S0015-0282(00)00490-8 ↗
24. 10.1016/0022-4804(90)90013-R10.1016/0022-4804(90)90013-R ↗
25. Butterfield TA · J Athl Train · 2006 · 4 · 457
26. 10.1096/fasebj.6.7.134871410.1096/fasebj.6.7.1348714 ↗
27. 10.1042/bj181063910.1042/bj1810639 ↗
28. 10.1016/S0142-9612(96)00106-810.1016/S0142-9612(96)00106-8 ↗
29. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
30. 10.1016/j.biomaterials.2011.10.05410.1016/j.biomaterials.2011.10.054 ↗
31. Gilbert TW · Biomaterials · 2006 · 27 · 3675
32. 10.1016/j.jamcollsurg.2011.01.00610.1016/j.jamcollsurg.2011.01.006 ↗
33. 10.1016/j.jamcollsurg.2010.04.02410.1016/j.jamcollsurg.2010.04.024 ↗
34. 10.1016/j.biomaterials.2008.09.00310.1016/j.biomaterials.2008.09.003 ↗
35. 10.1016/0006-2952(86)90328-X10.1016/0006-2952(86)90328-X ↗
36. 10.1007/s00464-006-9110-y10.1007/s00464-006-9110-y ↗
37. 10.1089/ten.tea.2007.031710.1089/ten.tea.2007.0317 ↗
38. 10.1002/bjs.728210.1002/bjs.7282 ↗
39. 10.1177/155335060933139710.1177/1553350609331397 ↗
40. 10.1016/j.surge.2012.02.00610.1016/j.surge.2012.02.006 ↗
41. 10.1002/jbm.b.3170410.1002/jbm.b.31704 ↗
42. 10.1007/s10029-011-0859-010.1007/s10029-011-0859-0 ↗
43. 10.1016/j.bjps.2008.04.06010.1016/j.bjps.2008.04.060 ↗
44. 10.1007/s11605-007-0242-810.1007/s11605-007-0242-8 ↗
45. 10.1007/s10029-010-0777-610.1007/s10029-010-0777-6 ↗